Table 3

Incidence of type 2 diabetes in subjects with NGT divided into three groups based on FPG

FPG (mg/dl)1-h PG (mg/dl)n (% of SAHS participants)FPG (mg/dl)1-h PG (mg/dl)2-h PG (mg/dl)OR (95% CI)
<90<125894 (72)81 ± 195 ± 2687 ± 111
125–150286 (73)82 ± 6135 ± 10100 ± 224.7 (2.0–11.1)
>150219 (72)83 ± 6175 ± 19109 ± 217.4 (3.3–17.1)
90–100<125489 (29)95 ± 399 ± 1494 ± 181.8 (0.6–5.2)
125–150255 (30)95 ± 3136 ± 10105 ± 192.7 (1.1–6.9)
>150265 (34)96 ± 3180 ± 18111 ± 2011.3 (5.0–25.8)
>100<125329 (7)106 ± 5102 ± 12101 ± 171.7 (0.4–6.7)
125–150277 (9)107 ± 5137 ± 10108 ± 194.0 (1.3–12.5)
>150432 (10)109 ± 6188 ± 27114 ± 1817.7 (7.5–41.9)
  • Data are means ± SD unless indicated otherwise. Subjects with NGT were divided into three groups based on FPG <90, 90–100, and >100 mg/dl. Subjects in each group were further subdivided based on a 1-h plasma glucose (PG) concentration <125, 125–155, and >155 mg/dl. Age, BMI, ethnicity, and systolic blood pressure were included as covariates in the model.